Event starts on September 22, 2017 9:00 am
September 22, 2017 9:00 am September 22, 2017 5:00 pm America/New_York Long Acting HIV Prevention Methods

The development of antiretroviral drugs for HIV has dramatically reduced disease burden for millions of people with access to adequate treatment and prevention programs. However, UNAIDS reports that 25 million people in Sub-Saharan Africa are still living with HIV, accounting for more than two-thirds of the infected population worldwide, and that women (aged 15-24) in this region are disproportionately impacted. Importantly, the number of young women at the cusp of this age range is currently very high, placing us at an important juncture. Without adequate intervention and a reduction in the rate of new infections, the most likely outcome is a resurgence of the HIV epidemic.

The scientific community must develop new and effective prevention strategies to reduce HIV transmission in order to prevent this devastating outcome. Taking into consideration economic, social, and cultural barriers to current HIV prevention strategies, approaches such as long-acting therapies are a promising path forward, however key questions remain before this approach can be put to use in community settings. This conference will address current scientific barriers to development of long-acting prevention methods for HIV.

Registration for this conference is FREE. Also available via webinar.

40.713152,-74.01190639999999

Description

The development of antiretroviral drugs for HIV has dramatically reduced disease burden for millions of people with access to adequate treatment and prevention programs. However, UNAIDS reports that 25 million people in Sub-Saharan Africa are still living with HIV, accounting for more than two-thirds of the infected population worldwide, and that women (aged 15-24) in this region are disproportionately impacted. Importantly, the number of young women at the cusp of this age range is currently very high, placing us at an important juncture. Without adequate intervention and a reduction in the rate of new infections, the most likely outcome is a resurgence of the HIV epidemic.

The scientific community must develop new and effective prevention strategies to reduce HIV transmission in order to prevent this devastating outcome. Taking into consideration economic, social, and cultural barriers to current HIV prevention strategies, approaches such as long-acting therapies are a promising path forward, however key questions remain before this approach can be put to use in community settings. This conference will address current scientific barriers to development of long-acting prevention methods for HIV.

Registration for this conference is FREE. Also available via webinar.

Additional information

Hosted by

Microbiology and Infectious Diseases Discussion Group, The Bill & Melinda Gates Foundation, The New York Academy of Sciences

Participation

Open, Registration Required

Location

Get directions

Contact

Website
https://www.nyas.org/events/2017/long-acting-hiv-prevention-methods/
Address
The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Reviews

There are no reviews yet.

Be the first to review “Long Acting HIV Prevention Methods”

Your email address will not be published. Required fields are marked *